ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Redha Souilamas
Marc Riquet
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagan, P.
Right arrow Articles by Riquet, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagan, P.
Right arrow Articles by Riquet, M.
Related Collections
Right arrow Lung - other

Ann Thorac Surg 2003;75:378-381
© 2003 The Society of Thoracic Surgeons


Original article: general thoracic

Catamenial pneumothorax: retrospective study of surgical treatment

Patrick Bagan, MDa, Françoise Le Pimpec Barthes, MDa, Jalal Assouad, MDa, Redha Souilamas, MDa, Marc Riquet, MD, PhDa*

a Service de Chirurgie Thoracique, Hôpital Européen Georges Pompidou, Paris, France

Accepted for publication August 24, 2002.

* Address reprint requests to Dr Riquet, Service de Chirurgie Thoracique, Hôpital Européen Georges Pompidou, 20-40 rue Leblanc, 75908 Paris, France
e-mail: marc.riquet{at}hop.egp.ap-hp-paris.fr


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
BACKGROUND: Catamenial pneumothorax is a rare entity characterized by recurrent accumulation of air in the thoracic space during menstruation. Catamenial pneumothorax is also associated with a high rate of postoperative recurrence. The aim of this study was to discuss the etiology and to determine the optimal surgical treatment of this entity.

METHODS: From December 1991 to September 2000, 10 patients with catamenial pneumothorax were treated at our institution. Median age at time of operation was 37 years (range, 21 to 44 years). We retrospectively evaluated the pathologic findings, the operation performed, and the results in all patients. The mean follow-up was 55.7 months.

RESULTS: Pleurodesis alone was performed in 5 patients and an associated diaphragmatic procedure was performed in 5 patients. In 5 patients, no diaphragmatic anomaly was discovered: 3 experienced one or more recurrences and all still suffer from chronic catamenial chest pain. Hormonal therapy temporarily improved outcome for 6 months in 2 patients. On the contrary, in 5 patients surgical pleurodesis was associated with the repair of diaphragmatic defects (simple closure or coverage by a polyglactin mesh): these patients experienced no recurrence (n = 0/5, p = 0.0016) and no subsequent catamenial chest pain.

CONCLUSIONS: The postoperative outcome is influenced by the diagnosis of diaphragmatic defects with or without endometriosis. Surgical treatment should be accomplished during menstruation for an optimal visualization of pleurodiaphragmatic endometriosis. Because diaphragmatic lesion is frequent and may be occult, we propose the systematic coverage of the diaphragmatic surface by a polyglactin mesh to prevent catamenial pneumothorax recurrence even when the diaphragm appears normal.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Recurrent spontaneous pneumothorax occurring in association with menstruation was first described by Maurer and colleagues [1] in 1958. Later, Lillington and colleagues [2] named this syndrome catamenial pneumothorax and presented 5 patients in 1972. The reports of catamenial pneumothorax (CPX) in the literature are rare and its physiologic mechanism remains unclear. Traditional therapy involving hormonal treatment or surgical pleurodesis seems to be associated with a high rate of recurrence [3]. The purpose of this retrospective study of 10 patient with CPX is to discuss the pathogenesis and to evaluate different methods of therapy for CPX.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
From December 1991 to September 2000, 10 patients presenting with CPX underwent surgical treatment for CPX at our institution. The criteria used for diagnosis of CPX were as follows: recurrent pneumothorax documented by chest radiograph during or preceding menstruation and association of recurrent pneumothorax with diaphragmatic endometriosis confirmed histologically. Clinical characteristics are presented in Table 1. Mean age of patients was 37.2 years (range, 21 to 44 years). Pneumothoraces were unilateral and right-sided in 8 patients, left-sided in 1 patient, and bilateral in 1 patient. Symptoms consistent with pelvic endometriosis were observed in 5 of the 10 patients. One patient had a history of catamenial hemoptysis and 5 patients had been previously operated for right recurrent pneumothorax (2 in our institution, 3 at other institutions). We reviewed the different surgical treatment performed and their results using {chi}2 analysis. All statistical analysis were performed using computerized software (StatView, Brain Power Inc, Calabasas, CA), with a p value of less than 0.05 considered as significant.


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical Details of Patientsa

 

    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Treatment
Pathologic findings, treatment, and outcome are presented in Table 2. Of the 10 patients, 6 underwent thoracoscopy and 4 underwent posterolateral thoracotomy (as a second procedure in 3 patients). Surgical pleurodesis (pleurectomy n = 5, pleural abrasion n = 5) was performed in all patients. Isolated diaphragmatic defects were observed in 2 patients. Diaphragmatic defects surrounded by endometrial implants were observed and confirmed by biopsy in 3 patients. The closure of diaphragmatic defects was obtained by interrupted sutures in all patients. During operation on patient 8 in 1997, we noticed an associated porous diaphragm. Because we feared to leave occult defects, we inserted a polyglactin mesh (Vicryl; Ethicon, Inc, Sommerville, NJ) through a thoracic approach to cover the tendinous part of the diaphragm. The mesh was held in place by stitches at its periphery. The same technique was used for the remainder of the patients. There was no complication (except one wound infection of a trocar port). The mean duration of chest tube drainage was 3.9 days (range, 2 to 6 days) and the mean duration of hospital stay was 5.4 days (range, 4 to 8 days). Hormonal treatment was proposed to 7 patients: 1 patient refused and another was unable to tolerate the treatment. Five patients received gonadotropin-releasing hormone agonists during 6 months: 2 after a surgical pleurodesis alone, 3 after diaphragmatic repair.


View this table:
[in this window]
[in a new window]
 
Table 2. Pathological Findings, Treatment, and Outcomea

 
Outcome
The mean duration of follow-up was 55.7 ± 34 months. We observed a high rate of recurrence after pleurodesis alone: 4 patients experienced one recurrence during menstruation and in 3 patients, the chest roentgenogram revealed a pneumothorax at the right base. Recurrences were all treated by placement of a chest tube. All patients (n = 5) treated by pleurodesis alone still suffer from chest pain during menstruation. Hormonal therapy during 6 months improved outcome in 2 of these 5 patients. On the contrary, diaphragmatic defect visualization and diaphragmatic repair procedures significantly improved outcome in 5 patients (p = 0.0016) with no recurrence and no pain after discontinuation of hormonal treatment.


    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Pathogenesis
The mechanism of CPX is unclear. Four proposed mechanisms for the cyclic occurrence of pneumothorax have been described in the literature. The first mechanism involves a congenital diaphragmatic fenestration or porosity. During menstruation, there is an open connection between the atmosphere and the peritoneal cavity because the cervical mucus plug is absent. Air can migrate through the fallopian tube into the abdominal cavity and through diaphragmatic fenestrations or porosities, mainly observed on the right side, causing a pneumothorax [46]. The second mechanism involves acquired diaphragmatic fenestrations caused by endometriosis. Endometrial tissue migrates to the diaphragm by retrograde flow from the uterus to the pelvis, hence in the peritoneal cavity to the subphrenic space [7]. When such endometrial tissue undergoes cyclical necrosis due to menstrual hormonal activity, the diaphragm perforates, producing a defect [8]. Endometrial tissue has been identified on the edges of the defect in many cases of CPX [911] (and in 5 patients in our population). Pneumoperitoneum can migrate through these defects to cause a pneumothorax during menstruation [12]. The third mechanism involves the metastatic spread of endometrial tissue. Endometrial implants find their way through the uterine veins in the venous system [13]. In this model, endometrial implants reach the lung parenchyma and cause focal defects on the pleural surface during menstruation leading to air leaks [14]. The fourth mechanism cites the release of dinaprost tromethamine (prostaglandin F2). During menstruation prostaglandin F2 may be present in the plasma of some women. It is a potent constrictor of bronchioles and vascular structures. Alveolar tissue damaged by vasospasm may cause pneumothorax if bronchospasm impedes expiration [15].

In accord with the above described, our patient population can be divided into two groups.

The first group is characterized by the presence of diaphragmatic defects (5 patients). Diaphragmatic defects were identified during the first procedure in 2 patients and during the second procedure in 3 patients. All of these patients had a history of severe pelvic endometriosis (infertility, chronic pelvic pain). These observations lend support for the mechanism involving diaphragmatic perforation caused by retrograde peritoneal implantation of endometrial tissue. Shiraishi [16] reported that diaphragmatic defects were found in 29% of patients with CPX in the English literature and in 66% of cases in the Japanese literature. In our series, diaphragmatic defects were identified during the second procedure in 60% of the patients (n = 3). Pleurodiaphragmatic endometriosis undergoes cyclical changes due to hormonal activity. During menstruation, implants are congestive, intermittent bleeding causes necrosis, and subsequently the diaphragm perforates. Afterward, the lesions transform into fibrous tissue. Therefore, we recommend a complete exploration of the diaphragmatic surface, with the optimal time for the surgical procedure being the period of menses.

In the second group, diaphragmatic defects were not visualized. One patient with bilateral recurrent CPX had a history of catamenial hemoptysis, which suggested the presence of parenchymal endometriosis. In this patient, lung metastasis of endometrial tissue through the venous system can explain the bilateral localization of parenchymal endometriosis.

Four patients with unilateral recurrent CPX (right-sided in 3 patients and left-sided in 1 patient) had only blebs on the pleural surface. Surgical blebs resection combined with pleurodesis was inadequate as seen by postoperative recurrence in 3 patients and chest pain during menstruation in all patients. In these patients, the mechanism of CPX is still unclear but chest roentgenograms revealed a pneumothorax at the right base in 3 patients, which suggests that the recurrences were probably due to unobserved diaphragmatic lesions.

Treatment
Current treatment of CPX combines the principles of treatment of spontaneous pneumothorax with that of hormonal treatment. Because a direct relation between menstruation and pneumothorax has been demonstrated, prophylactic hormonal therapy used to suppress ectopic endometrium activity by blocking hormonal support from the ovary is warranted. Gonadotropin-releasing hormone agonists induce an hypogonadotropic hypogonadism. The side effects are those of hypoestrogenism, especially osteoporosis, which limits duration of the treatment to 6 months [17]. In our patients, this treatment was not helpful when diaphragmatic repair was not performed. Apical pleurodesis can be achieved using pleural abrasion or pleurectomy, but this method does not prevent diaphragmatic perforation and catamenial chest pain that are, in the majority of the patients, both induced by cyclical proliferation of microscopical endometrial implants [3]. In 3 patients, we lined the diaphragm with a polyglactin mesh. This technique was performed for fear of leaving behind small defects. The goals of polyglactin mesh insertion was to reinforce the diaphragmatic surface, to induce fibrotic adhesion with the lung [18], and to contain and prevent diaphragmatic perforation by endometrial implants. The good results obtained with this technique (no recurrence and no chest pain after the interruption of hormonal treatment for a mean follow-up of 35 months [range, 30 to 45 months]), suggest to use more widely this technique when no diaphragmatic defect is discovered during operation. In fact, recurrence may be due to diaphragmatic defects with or without endometriosis. This was probably the case in our 3 patients who experienced postoperative recurrences at the right base and who may have benefited from this procedure.

To conclude, with respect to our series and reports in the literature, there is considerable evidence to support the involvement of endometriosis in the pathogenesis of CPX. It is important to differentiate between pulmonary endometriosis, which appears to be the result of vascular metastasis, and diaphragmatic endometriosis, which is presumed to be more frequent than reported in the literature. Conventional treatment of CPX appears to be insufficient, but when diaphragmatic lesions are visualized, appropriate treatment significantly improves patient outcome. This observation focuses on the importance of exploration of the diaphragm during menstruation. However, when diaphragmatic endometriosis is suspected during CPX but not observed during operation, we suggest lining of the diaphragm with a polyglactin mesh to help prevent recurrence.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 

  1. Maurer E.R., Schaal J.A., Mendez F.L., Jr Chronic recurring spontaneous pneumothorax due to endometriosis of the diaphragm. JAMA 1958;168:2013-2014.
  2. Lillington G.A., Mitchell S.P., Wood G.A. Catamenial pneumothorax. JAMA 1972;219:1328-1332.[Abstract/Free Full Text]
  3. Joseph J., Sahn S.A. Thoracic endometriosis syndrome: new observations from a analysis of 110 cases. Am J Med 1996;100:164-169.[Medline]
  4. Crutcher R.R., Waltuch T.L., Blue M.E. Recurrent spontaneous pneumothorax associated with menstruation. J Thorac Cardiovasc Surg 1967;54:599-602.[Medline]
  5. Funatsu K., Tsuru M., Hayabuchi N. Catamenial pneumothorax and its relation to the peritoneal stomata of the diaphragm. Chest 1999;116:1843.[Free Full Text]
  6. Brichon P.Y., Riquet M., Milongo R. Epanchement pleural atypique par communication transdiaphragmatique. Ann Chir: Chir Thorac Cardio-vasc 1992;46:170-173.
  7. Foster D.C., Stern J.L., Buscema I. Pleural and parenchymal endometriosis. Obstet Gynecol 1981;58:555.
  8. Kirschner P.A. Porous diaphragm syndromes. Chest Surg Clin North Am 1998;8:449-472.[Medline]
  9. Soderberg C.H., Dahlquist E.H. Catamenial pneumothorax. Surgery 1976;79:236-239.[Medline]
  10. Blanco S., Hernando F., Gomez A. Catamenial pneumothorax caused by diaphragmatic endometriosis. J Thorac Cardiovasc Surg 1998;116:179-180.[Free Full Text]
  11. Slasky B.S., Siewers R.D., Lecky J.W. Catamenial pneumothorax: the role of diaphragmatic defects and endometriosis. AJR 1982;138:539-542.
  12. Downey D.B., Towers M.J., Poom P.Y. Pneumoperitoneum with catamenial pneumothorax. AJR 1990;155:29-30.[Free Full Text]
  13. Shearin R.P.N., Hepper N.G.G., Payne W.S. Recurrent spontaneous pneumothorax concurrent with menses. Mayo Clinic Proc 1974;49:98-101.[Medline]
  14. Van Schil P.E., Vercauteren S.R., Vermeire P. Catamenial pneumothorax caused by thoracic endometriosis. Ann Thorac Surg 1996;62:585-586.[Abstract/Free Full Text]
  15. Rossi N.P., Goplerud C.P. Recurrent catamenial pneumothorax. Arch Surg 1974;109:173-176.[Abstract/Free Full Text]
  16. Shiraishi T. Catamenial pneumothorax: report of a case and review of the Japanese and non-Japanese literature. Thorac Cardiovasc Surgeon 1991;39:304-307.[Medline]
  17. Olive D.L., Pritts E.A. Treatment of endometriosis. N Engl J Med 2001;345:266-274.[Free Full Text]
  18. Sugarmann W.M., Widmann W.D., Mysh D. Mesh insertion as an aid for pleurodesis. J Cardiovasc Surg(Torino) 1996;37:173-175.



This article has been cited by other articles:


Home page
ICVTSHome page
P. Ciriaco, G. Negri, L. Libretti, A. Carretta, G. Melloni, M. Casiraghi, A. Bandiera, and P. Zannini
Surgical treatment of catamenial pneumothorax: a single centre experience
Interactive CardioVascular and Thoracic Surgery, March 1, 2009; 8(3): 349 - 352.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. Rafay, H. El-Bawab, W. Kurdi, and K. Al Kattan
Diaphragmatic Fenestrations in Catamenial Pneumothorax: a Management Strategy
Asian Cardiovasc Thorac Ann, January 1, 2009; 17(1): 70 - 72.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. A. Ali, M. Lippmann, U. Mundathaje, and G. Khaleeq
Spontaneous Hemothorax: A Comprehensive Review
Chest, November 1, 2008; 134(5): 1056 - 1065.
[Full Text] [PDF]


Home page
Eur Respir JHome page
P. Bagan, P. Berna, J. Assouad, V. Hupertan, F. Le Pimpec Barthes, and M. Riquet
Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax
Eur. Respir. J., January 1, 2008; 31(1): 140 - 142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Alifano, C. Jablonski, H. Kadiri, P. Falcoz, A. Gompel, S. Camilleri-Broet, and J.-F. Regnard
Catamenial and Noncatamenial, Endometriosis-related or Nonendometriosis-related Pneumothorax Referred for Surgery
Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 1048 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Vercellini, A. Abbiati, P. Vigano, E.D. Somigliana, R. Daguati, F. Meroni, and P.G. Crosignani
Asymmetry in distribution of diaphragmatic endometriotic lesions: evidence in favour of the menstrual reflux theory
Hum. Reprod., September 1, 2007; 22(9): 2359 - 2367.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
A. Bobbio, P. Carbognani, L. Ampollini, and M. Rusca
Diaphragmatic Laceration, Partial Liver Herniation and Catamenial Pneumothorax
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 249 - 251.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Alifano, R. Trisolini, A. Cancellieri, and J. F. Regnard
Thoracic Endometriosis: Current Knowledge
Ann. Thorac. Surg., February 1, 2006; 81(2): 761 - 769.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Bagan, F. Le Pimpec-Barthes, E. Martinod, M. Brauner, J. F. Azorin, and M. Riquet
Magnetic Resonance Images of Diaphragmatic Endometriosis Treated by Polyglactin Mesh
Ann. Thorac. Surg., January 1, 2006; 81(1): 373 - 373.
[Full Text] [PDF]


Home page
ChestHome page
H. Black, D. Sigal, D. Barnes, C. Felisky, D. Follette, and R. Harper
A 25-Year-Old Patient With Spontaneous Hemothorax
Chest, October 1, 2005; 128(4): 3080 - 3083.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Alifano, P. Magdeleinat, and J. F. Regnard
Catamenial pneumothorax: Some commentaries
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1199 - 1199.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
T. Peikert, D. J. Gillespie, and S. D. Cassivi
Catamenial Pneumothorax
Mayo Clin. Proc., May 1, 2005; 80(5): 677 - 680.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. B. Marshall, Z. Ahmed, J. C. Kucharczuk, L. R. Kaiser, and J. B. Shrager
Catamenial pneumothorax: optimal hormonal and surgical management
Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 662 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Korom, H. Canyurt, A. Missbach, D. Schneiter, M. O. Kurrer, U. Haller, P. J. Keller, M. Furrer, and W. Weder
Catamenial pneumothorax revisited: Clinical approach and systematic review of the literature
J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 502 - 508.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Redha Souilamas
Marc Riquet
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagan, P.
Right arrow Articles by Riquet, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagan, P.
Right arrow Articles by Riquet, M.
Related Collections
Right arrow Lung - other


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS